Victory Capital Management Inc Aclaris Therapeutics, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$9.74 - $17.92 $220,611 - $405,888	-22,650 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$12.27 - $18.49 $140,565 - $211,821	-11,456 Reduced 33.59%	22,650 $329,000
Q3 2021 Nov 02, 2021	BUY	$13.38 - $18.8 $217,853 - $306,101	16,282 Added 91.35%	34,106 $614,000
Q2 2021 Aug 03, 2021	BUY	$17.08 - $29.6 $166,461 - $288,481	9,746 Added 120.65%	17,824 $313,000
Q1 2021 May 04, 2021	BUY	$5.86 - $27.73 $47,337 - $224,002	8,078 New	8,078 $204,000
Q2 2020 Aug 07, 2020	SELL	$1.04 - $1.73 $6,584 - $10,952	-6,331 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$0.75 - $2.18 $36 - $104	-48 Reduced 0.75%	6,331 $7,000
Q4 2019 Feb 04, 2020	SELL	$1.02 - $1.97 $541 - $1,046	-531 Reduced 7.68%	6,379 $8,000
Q3 2019 Nov 12, 2019	BUY	$0.79 - $2.47 $5,458 - $17,067	6,910 New	6,910 $7,000
Q2 2019 Aug 15, 2019	SELL	$2.13 - $7.06 $217,794 - $721,892	-102,251 Closed	0 $0
Q1 2019 May 03, 2019	BUY	$5.63 - $7.84 $168,731 - $234,964	29,970 Added 41.46%	102,251 $612,000
Q4 2018 Feb 05, 2019	SELL	$6.3 - $15.4 $8,505 - $20,790	-1,350 Reduced 1.83%	72,281 $534,000
Q3 2018 Nov 01, 2018	SELL	$14.38 - $20.89 $53,781 - $78,128	-3,740 Reduced 4.83%	73,631 $1.07 Million
Q2 2018 Aug 02, 2018	SELL	$16.46 - $20.33 $67,815 - $83,759	-4,120 Reduced 5.06%	77,371 $1.55 Million
Q1 2018 May 04, 2018	BUY	$17.08 - $25.64 $136,469 - $204,863	7,990 Added 10.87%	81,491 $1.43 Million
Q4 2017 Feb 01, 2018	BUY	$21.47 - $27.8 $306,806 - $397,262	14,290 Added 24.13%	73,501 $1.81 Million
Q3 2017 Oct 27, 2017	BUY	$23.02 - $28.8 $418,733 - $523,872	18,190 Added 44.34%	59,211 $1.53 Million
Q2 2017 Aug 07, 2017	BUY	N/A	41,021	41,021 $1.11 Million

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.4 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.9 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.9 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.5 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account